Jessica Barry

Allison Truong, M.D., FAAD, provides some useful tips to help health care professionals on the frontlines of the COVID-19 pandemic combat mask irritation and acne.

With the rise in face mask usage, multiple types of masks have entered the market made of a variety of materials. Some, however, can lead to more skin irritation than others. Allison Truong, M.D., FAAD, provides some suggestions for the best type of mask to use and how to reduce skin irritation.

In this video interview, Allison Truong, M.D., FAAD, explains various measures that can be taken to prevent maskne, including pinpointing the root cause of the irritation.

Allison Truong, M.D., FAAD, provides some tips on how to treat mask-related acne, or otherwise known as ’maskne.’

Allison Truong, M.D., FAAD, explains what 'maskne' is and the various types of acne that can occur when wearing a mask.

Vinod E. Nambudiri, M.D., MBA, breaks down tools the specialty can use to expand telehealth services to underserved communities.

What are some of the challenges of expanding teledermatology to underserved communities? Sepideh Ashrafzadeh answers this question in part four of our video interview.

In part three of our conversation, Sepideh Ashrafzadeh details sustainable steps the specialty can take to expand access to care to new and underserved communities during the current pandemic – and in the future.

In part two of our conversation on expanding care to underserved populations through telehealth, expert Vinod E. Nambudiri, M.D., MBA, dives into the disparities that most affect the specialty of dermatology.

Could the eased telehealth restrictions implemented in response to the COVID-19 pandemic allow for greater access to dermatologic care? We sat down with experts to explore how telehealth could be used to expand quality care to vulnerable and underserved populations across the United States.

Vitiligo can be psychologically devastating for patients. Expert Seemal R. Desai, M.D., FAAD, shares how recent advances in vitiligo treatment offer hope to patients impacted by the disease.

Subtypes such as confetti vitiligo and trichrome vitiligo can be signs of unstable active disease, says expert Seemal R. Desai, M.D., FAAD.

Expert Seemal R. Desai, M.D., FAAD, highlights new therapeutics that may impact the future of vitiligo management, a topic he discussed at the AAD Virtual Meeting Experience (VMX) in June.

Antioxidants can be a valuable part of your vitiligo therapeutic armamentarium, says expert Seemal R. Desai, M.D., FAAD.

Expert Seemal R. Desai, M.D., FAAD, offers practical tips for stabilizing patients who present with active, spreading vitiligo, a topic he discussed at the AAD Virtual Meeting Experience (VMX) in June.

Is your patient’s vitiligo stable, unstable or recalcitrant? Expert Seemal R. Desai, M.D., FAAD, discusses how he classifies disease activity in his practice.

Expert Seemal R. Desai, M.D., FAAD, stresses the importance of defining treatment goals when meeting with vitiligo patients, a topic he covered during his presentation at the AAD Virtual Meeting Experience (VMX) in June.

Expert Christine Ko, M.D., FAAD, discusses case reports exploring the variability of skin manifestation in patients with or suspected of COVID-19 infection.

Most skin manifestations associated with COVID-19 resolve as the disease progresses, says expert Christine Ko, M.D., FAAD. But there is one type of lesion that providers and patients will not want to ignore, she warns.

Learn about the histopathology of skin findings associated with potential COVID-19 infection from expert Christine Ko, M.D., FAAD.

Will the current practice of using telemedicine for acne care have an impact on the future of dermatology? We spoke with Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, on the topic.

Virtual visits may allow providers to focus more on patient education, says Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama.

Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, discusses how she approaches treating acne via virtual visits after incorporating telemedicine into her practice due to the COVID-19 pandemic.

Is telemedicine a useful tool to treat acne during the COVID-19 pandemic? Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, shares her insights.

Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, emphasizes the importance of ensuring timely treatment of acne patients during the COVID-19 crisis.

COVID-19 has left providers with fewer in-office visits, more telehealth appointments and, for many, reduced revenue.

The American College of Physicians (ACP) claims the changes to payments for offices visits will benefit physicians and practices.

The Centers for Medicare & Medicaid Services (CMS) has proposed a permanent expansion of telehealth to ensure healthcare access in rural areas.

Due to the financial fallout caused by COVID-19, many practices are struggling to keep their doors open. What options to physicians have? This expert says hope lies within value-based care.

Hema Sundaram, MA, MD, FAAD, highlights an exciting new technology that may change the future of aesthetic therapeutics.